Publications

Novan’s team of top-tier scientists has published extensively about the safety and efficacy of nitric oxide, in leading medical publications like the Journal of Drugs in Dermatology, the American Society for Microbiology, and the Journal of Clinical and Aesthetic Dermatology.

Year
Title
2022

Results of Phase 2 Study Evaluating the Efficacy and Safety of SB206, Topical Berdazimer Sodium Gel, in Subjects With Molluscum Contagiosum

2022

BOTE (Beginning of the End) Is a Clinical Sign of Molluscum Contagiosum Resolution Enhanced by SB206, an Investigational Nitric Oxide–Releasing Topical Medication

2021

SB206, a Nitric Oxide–Releasing Topical Medication, Induces the Beginning of the End Sign and Molluscum Clearance

2020

A Nitric Oxide-releasing Topical Medication as a Potential Treatment Option for Atopic Dermatitis Through Antimicrobial and Anti-inflammatory Activity

2019

Efficacy and Tolerability of an Investigational Nitric Oxide-releasing Topical Gel in Patients With Molluscum Contagiosum: A Randomized Clinical Trial

2019

NVN1000, a Novel Nitric Oxide-Releasing Compound, Inhibits HPV-18 Virus Production by Interfering with E6 and E7 Oncoprotein Functions

2018

A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis

2018

Nitric Oxide-Releasing Macromolecule Exhibits Broad-Spectrum Antifungal Activity and Utility as a Topical Treatment for Superficial Fungal Infections

2018

A Phase 2 Controlled Study of SB206, a Topical Nitric Oxide-Releasing Drug for Extragenital Wart Treatment

2016

Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne Vulgaris